14 Results for "

psychotic disorders

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "psychotic disorders" in MCE Product Catalog:

22
22 Publications Verification
Cat. No.: HY-14538B
CAS No.: 53515-91-6
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease Cancer

Haloperidol lactate is a potent antipsychotic agent. Haloperidol lactate can be used in acute and chronic schizophrenia and gilles de la tourette's syndrome. Haloperidol lactate has the potential for the research of psychotic disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116916
CAS No.: 2751-68-0
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Acetophenazine, a phenothiazine derivative, is an antipsychotic agent. Acetophenazine primarily blocks dopamine D2 receptors in the brain. Acetophenazine can be used for researching psychotic disorders such as schizophrenia and anxious depression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1262
CAS No.: 5714-00-1
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Acetophenazine dimaleate, a phenothiazine derivative, is an antipsychotic agent. Acetophenazine dimaleate primarily blocks dopamine D2 receptors in the brain. Acetophenazine dimaleate can be used for researching psychotic disorders such as schizophrenia and anxious depression .
loading...
    loading...
Cat. No.: HY-119393
CAS No.: 174794-02-6
Purity:  98.02%
Target:  

Others

Research Areas:  

Neurological Disease

Olanzapine N-oxide is a phase I metabolite of Olanzapine (HY-14541). Olanzapine N-oxide serves as a substrate for reduction reactions and converts to Olanzapine in whole blood in vitro. Olanzapine is an antipsychotic compound widely used in research on schizophrenia and other psychotic disorders .
loading...
    loading...
Cat. No.: HY-101313A
CAS No.: 73220-03-8
Purity:  99.93%
Synonyms: (-)-Remoxipride hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

(S)-Remoxipride ((-)-Remoxipride) hydrochloride is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride hydrochloride can be used for the research of psychotic disorder .
loading...
    loading...
Cat. No.: HY-101313
CAS No.: 80125-14-0
Synonyms: (-)-Remoxipride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

(S)-Remoxipride ((-)-Remoxipride) is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride can be used for the research of psychotic disorder .
loading...
    loading...
Cat. No.: HY-137546
CAS No.: 34104-67-1
Synonyms: Haloperidol metabolite II
Target:  

Drug Metabolite

Reduced Haloperidol (Haloperidol metabolite II) is an antipsychotic compound with neurotransmitter modulating activity. Reduced Haloperidol is commonly used to inhibit schizophrenia and other psychotic disorders. Reduced Haloperidol helps reduce the occurrence of hallucinations and delusions by inhibiting the activity of dopamine receptors.
loading...
    loading...
Cat. No.: HY-W741434
CAS No.: 1331636-00-0
Acetophenazine dimaleate-d4 is the deuterium labeled Acetophenazine (dimaleate) (HY-B1262). Acetophenazine dimaleate, a phenothiazine derivative, is an antipsychotic agent. Acetophenazine dimaleate primarily blocks dopamine D2 receptors in the brain. Acetophenazine dimaleate can be used for researching psychotic disorders such as schizophrenia and anxious depression .
loading...
    loading...
Cat. No.: HY-107081
CAS No.: 172940-14-6
Target:  

Dopamine Receptor UGT

Research Areas:  

Neurological Disease

Berupipam hemifumarate is a selective antagonist of the dopamine D1 receptor (dopamine D1 receptor). Berupipam hemifumarate is a substrate of UDP-glucuronosyltransferase (UGT) and has a high affinity for UGT enzymes but a relatively low conversion rate. The glucuronidation rate of Berupipam hemifumarate varies among different species and genders. Berupipam hemifumarate can be used for the study of psychotic disorders .
loading...
    loading...
Cat. No.: HY-101313B
CAS No.: 117591-79-4
Synonyms: (-)-Remoxipride hydrochloride hydrate
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

(S)-Remoxipride ((-)-Remoxipride) hydrochloride hydrate ((S)-Remoxipride hydrochloride hydrate) is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride hydrochloride hydrate can be used for the research of psychotic disorder .
loading...
    loading...
Cat. No.: HY-187871
CAS No.: 2854332-29-7
Grexenetant (compound I) is a NK-3 receptor antagonist. Grexenetant can be used in the research of diseases mediated by NK-3 receptors, such as depression, anxiety, psychosis, schizophrenia, psychotic disorders, bipolar disorder, cognitive impairment, Parkinson's disease, Alzheimer's disease, attention deficit hyperactivity disorder, pain, convulsions, obesity, inflammatory diseases, vomiting, preeclampsia, airway-related diseases, reproductive disorders, sex hormone-dependent diseases, gynecological diseases, and menopausal syndrome .
loading...
    loading...
Cat. No.: HY-183945
CAS No.: 1313195-84-4
WO-459 is a potent Gpr52 agonist. WO-459 induces dose-dependent elevation of intracellular cAMP in cells expressing Gpr52. WO-459 can be used for the research of Huntington’s disease and psychotic disorders .
loading...
    loading...
Cat. No.: HY-119393S
CAS No.: 1189732-75-9
Research Areas:  

Neurological Disease

Olanzapine N-Oxide-d3 is the d3-labeled Olanzapine N-oxide (HY-119393). Olanzapine N-oxide is a phase I metabolite of Olanzapine (HY-14541). Olanzapine N-oxide serves as a substrate for reduction reactions and converts to Olanzapine in whole blood in vitro. Olanzapine is an antipsychotic compound widely used in research on schizophrenia and other psychotic disorders .
loading...
    loading...
Cat. No.: HY-184802
CAS No.: 80273-79-6
Research Areas:  

Neurological Disease

Tefludazine is an orally active antagonist of dopamine D2 receptor with an IC50 of 8.8 nM and 5-HT2 receptor with an IC50 of 8.6 nM. Tefludazine moderately inhibits the uptake of dopamine, norepinephrine and serotonin in rat brain synaptosomes, with IC50 values of 520 nM, 660 nM and 7000 nM, respectively . Tefludazine exhibits long-acting antipsychotic activity, lacks anticholinergic activity, shows Clozapine (HY-14539)-like effects at low doses and Haloperidol (HY-14538)-like effects at high doses. Tefludazine can be used for the research of psychotic disorders .
loading...
    loading...
  • 1